0001062993-24-018931.txt : 20241112 0001062993-24-018931.hdr.sgml : 20241112 20241112174156 ACCESSION NUMBER: 0001062993-24-018931 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241108 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heino Mary Anne CENTRAL INDEX KEY: 0001610676 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36569 FILM NUMBER: 241450162 MAIL ADDRESS: STREET 1: C/O LANTHEUS HOLDINGS, INC. STREET 2: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: NY ZIP: 01862 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lantheus Holdings, Inc. CENTRAL INDEX KEY: 0001521036 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 352318913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 BUSINESS PHONE: 978 671-8001 MAIL ADDRESS: STREET 1: 331 TREBLE COVE ROAD CITY: NORTH BILLERICA STATE: MA ZIP: 01862 FORMER COMPANY: FORMER CONFORMED NAME: Lantheus MI Holdings, Inc. DATE OF NAME CHANGE: 20110517 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-11-08 0001521036 Lantheus Holdings, Inc. LNTH 0001610676 Heino Mary Anne C/O LANTHEUS HOLDINGS, INC. 201 BURLINGTON ROAD, SOUTH BLDG BEDFORD MA 01730 1 0 0 0 1 Common Stock 2024-11-08 4 S 0 7487 86.32 D 447436 D Common Stock 2024-11-08 4 S 0 400 86.93 D 447036 D Common Stock 2024-11-08 4 S 0 2900 88.78 D 444136 D Common Stock 2024-11-08 4 S 0 700 89.58 D 443436 D Common Stock 37720 I By Grantor Retained Annuity Trust Common Stock 130134 I By Grantor Retained Annuity Trust The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.84 to $86.75, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH"), any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.85 to $87.04, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.30 to $89.10, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.38 to $89.86, inclusive. The reporting person undertakes to provide to LNTH, any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. /s/ Daniel M. Niedzwiecki, attorney-in-fact 2024-11-12